A.RusjanP
According to Malhotra, Its always been good practice to treat both the sleep apnea and the obesity in the sense that, if somebody has excess weight, rather than just giving them a CPAP, ideally treat the body weight and the sleep apneanot either/or. GLP-1 use doesnt appear to be causing patients to simply abandon their CPAP, either
Tenere fuori dalla portata dei bambini al di sotto dei tre anni di et
Programs that pair medication with basic nutrition and activity guidance tend to produce better outcomes than medication alone
GLP-1 agonists are expensive, with monthly costs often exceeding $900-1,300 without insurance coverage
These were tested first, followed by secondary endpoints in a predefined order, including achieving weight loss of at least 10% or 15% at week 104, and changes in waist circumference and systolic blood pressure from baseline to week 104